PDCD1 and head and neck squamous cell carcinoma: Given the limited literature, this systematic review and meta-analysis of nine carefully selected randomized controlled trials (RCTs) was performed to evaluate the pooled efficacy and safety of anti-PD-1/PD-L1 monotherapy in recurrent/metastatic HNSCC compared with standard therapy.